Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2GCe4O5
via IFTTT